Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules

Isolated peptides derived from mage tumor rejection antigen precursors which complex with HLA-A2 molecules

US Patent 6682731 · Granted Jan 27, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Beta-catenin inhibitors in cancer immunotherapy2024
Methods and compositions related to T-cell activity2023
Microbiome biomarkers immunotherapy responsiveness: diagnostic, prognostic and t2023
Dysfunctional antigen-specific CD8+ T cells in the tumor microenvironment2023
Anti-GARP protein2022
Synergistic combination of immunologic inhibitors for the treatment of cancer2021
Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B vi2021
Nucleic acids encoding GARP-TGF-beta 1 antibodies2020
Method of screening for anti-GARP antibodies2020
Methods and compositions related to T-cell activity2020
GARP-TGF-β 1 IGG antibodies2020
Beta-catenin inhibitors in cancer immunotherapy2020